HA has also demonstrated tumor-targeting ability due to its high affinity for CD44, a family of single-pass transmembrane glycoproteins overexpressed in a variety of cancer cells and recognized as a surface marker for cancer stem cells (CSCs) [11,102]. This evidence concerns the gene CD44 and neoplasm.